Perrigo Announces Issue Of Approvable Letter By FDA For Dexcel's OTC Omeprazole

Tue, 19 Dec 2006 02:00 PM EST

... The Perrigo Company (Nasdaq: PRGO; TASE) announced today that the U. S. Food & Drug Administration (FDA) has issued an approvable letter for Dexcel Pharma Technologies, Ltd.'s New Drug Application (NDA) for 20 mg omeprazole delayed-release tablets. As previously disclosed, Perrigo will be Dexcel Pharma Technologies, Ltd. [click link for full article] ...